WallStreetZenWallStreetZen

NASDAQ: EVOK
Evoke Pharma Inc Stock

$0.65-0.01 (-1.52%)
Updated Mar 1, 2024
EVOK Price
$0.65
Fair Value Price
-$0.12
Market Cap
$2.17M
52 Week Low
$0.56
52 Week High
$3.70
P/E
-0.29x
P/B
-2.49x
P/S
1.07x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.30M
Earnings
-$7.61M
Gross Margin
92.3%
Operating Margin
-165.27%
Profit Margin
-176.9%
Debt to Equity
-9.99
Operating Cash Flow
-$6M
Beta
0.59
Next Earnings
Mar 19, 2024
Ex-Dividend
N/A
Next Dividend
N/A

EVOK Overview

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how EVOK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

EVOK ($0.65) is overvalued by 653.21% relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
EVOK ($0.65) is not significantly undervalued (653.21%) relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
EVOK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more EVOK due diligence checks available for Premium users.

Be the first to know about important EVOK news, forecast changes, insider trades & much more!

EVOK News

Valuation

EVOK fair value

Fair Value of EVOK stock based on Discounted Cash Flow (DCF)
Price
$0.65
Fair Value
-$0.12
Undervalued by
653.21%
EVOK ($0.65) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
EVOK ($0.65) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
EVOK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

EVOK price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.29x
Industry
59.58x
Market
36.17x

EVOK price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-2.49x
Industry
2.26x

EVOK's financial health

Profit margin

Revenue
$1.6M
Net Income
-$1.7M
Profit Margin
-108.4%
EVOK's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
EVOK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.9M
Liabilities
$8.7M
Debt to equity
-9.99
EVOK's short-term assets ($7.84M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
EVOK's short-term assets ($7.84M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
EVOK's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
EVOK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.0M
Investing
$0.0
Financing
$0.0
EVOK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

EVOK vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
EVOK$2.17M-1.81%-0.29x-2.49x
RDHL$2.17M-8.28%-0.07x0.62x
AGRX$2.13M+6.92%0.01x-0.17x
YCBD$2.22M+8.79%-0.06x0.32x
SNOA$2.42M+5.44%-0.16x0.36x

Evoke Pharma Stock FAQ

What is Evoke Pharma's quote symbol?

(NASDAQ: EVOK) Evoke Pharma trades on the NASDAQ under the ticker symbol EVOK. Evoke Pharma stock quotes can also be displayed as NASDAQ: EVOK.

If you're new to stock investing, here's how to buy Evoke Pharma stock.

What is the 52 week high and low for Evoke Pharma (NASDAQ: EVOK)?

(NASDAQ: EVOK) Evoke Pharma's 52-week high was $3.70, and its 52-week low was $0.56. It is currently -82.43% from its 52-week high and 16.49% from its 52-week low.

How much is Evoke Pharma stock worth today?

(NASDAQ: EVOK) Evoke Pharma currently has 3,343,070 outstanding shares. With Evoke Pharma stock trading at $0.65 per share, the total value of Evoke Pharma stock (market capitalization) is $2.17M.

Evoke Pharma stock was originally listed at a price of $140.88 in Sep 25, 2013. If you had invested in Evoke Pharma stock at $140.88, your return over the last 10 years would have been -99.54%, for an annualized return of -41.6% (not including any dividends or dividend reinvestments).

How much is Evoke Pharma's stock price per share?

(NASDAQ: EVOK) Evoke Pharma stock price per share is $0.65 today (as of Mar 1, 2024).

What is Evoke Pharma's Market Cap?

(NASDAQ: EVOK) Evoke Pharma's market cap is $2.17M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Evoke Pharma's market cap is calculated by multiplying EVOK's current stock price of $0.65 by EVOK's total outstanding shares of 3,343,070.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.